<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Clinical Lab Sciences Faculty Research and Publications</title>
<copyright>Copyright (c) 2013 Marquette University All rights reserved.</copyright>
<link>http://epublications.marquette.edu/clinical_lab_fac</link>
<description>Recent documents in Clinical Lab Sciences Faculty Research and Publications</description>
<language>en-us</language>
<lastBuildDate>Sat, 26 Jan 2013 10:52:37 PST</lastBuildDate>
<ttl>3600</ttl>








<item>
<title>Supraspinal Fatigue Is Similar in Men and Women for a Low-Force Fatiguing Contraction</title>
<link>http://epublications.marquette.edu/clinical_lab_fac/2</link>
<guid isPermaLink="true">http://epublications.marquette.edu/clinical_lab_fac/2</guid>
<pubDate>Tue, 24 Jul 2012 12:31:32 PDT</pubDate>
<description>
	<![CDATA[
	<p>Purpose: This study determined the contribution of supraspinal fatigue to the sex difference in neuromuscular fatigue for a low-intensity fatiguing contraction. Because women have greater motor responses to arousal than men, we also examined whether cortical and motor nerve stimulation, techniques used to quantify central fatigue, would alter the sex difference in muscle fatigue.</p>
<p>Methods: In study 1, cortical stimulation was elicited during maximal voluntary contractions (MVC) before and after a submaximal isometric contraction at 20% MVC with the elbow flexor muscles in 29 young adults (20 ± 2.6 yr, 14 men). In study 2, 10 men and 10 women (19.1 ± 2.9 yr) performed a fatiguing contraction in the presence and absence of cortical and motor nerve stimulation.</p>
<p>Results: Study 1: Men had a briefer time to task failure than women (<em>P</em> = 0.009). Voluntary activation was reduced after the fatiguing contraction (<em>P</em> < 0.001) similarly for men and women. Motor-evoked potential area and the EMG silent period increased similarly with fatigue for both sexes. Peak relaxation rates, however, were greater for men than women and were associated with time to task failure (<em>P</em> < 0.05). Force fluctuations, RPE, HR, and mean arterial pressure increased at a greater rate for men than for women during the fatiguing contraction (<em>P</em> < 0.05). Study 2: Time to task failure, force fluctuations, and all other physiological variables assessed were similar for the control session and stimulation session (<em>P</em>> 0.05) for both men and women.  <p id="x-x-x-x-x-x-x-x-x-x-P16">Conclusions: Supraspinal fatigue was similar for men and women after the low-force fatiguing contraction, and the sex difference in muscle fatigue was associated with peripheral mechanisms. Furthermore, supraspinal fatigue can be quantified in both men and women without influencing motor performance.</p>

	]]>
</description>

<author>Manda L. Keller et al.</author>


</item>






<item>
<title>Molecular Diagnosis of Sexually-transmitted Chlamydia trachomatis in the United States</title>
<link>http://epublications.marquette.edu/clinical_lab_fac/1</link>
<guid isPermaLink="true">http://epublications.marquette.edu/clinical_lab_fac/1</guid>
<pubDate>Wed, 18 Jul 2012 13:12:17 PDT</pubDate>
<description>
	<![CDATA[
	<p>Chlamydia, with its Chlamydia trachomatis etiology, is the most common bacterial sexually transmitted infection in the United States and is often transmitted via asymptomatic individuals. This review summarizes traditional and molecular-based diagnostic modalities specific to C. trachomatis. Several commercially available, FDA-approved molecular methods to diagnose urogenital C. trachomatis infection include nucleic acid hybridization, signal amplification, polymerase chain reaction, strand displacement amplification, and transcription-mediated amplification. Molecular-based methods are rapid and reliable genital specimen screening measures, especially when applied to areas of high disease prevalence. However, clinical and analytical sensitivity for some commercial systems decreases dramatically when testing urine samples. In vitro experiments and clinical data suggest that transcription-mediated amplification has greater analytical sensitivity than the other molecular-based methods currently available. This difference may be further exhibited in testing of extragenital specimens from at-risk patient demographics. The development of future molecular testing could address conundrums associated with confirmatory testing, medicolegal testing, and test of cure.</p>

	]]>
</description>

<author>April Harkins et al.</author>


</item>





</channel>
</rss>
